Fundraising FoxPace Ventures — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
Bitfount provides a federated learning and data science platform that enables organizations to run AI models, conduct analytics, and perform model training on private data without transferring it to third parties.
AI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHealthtechLondon, GB
PartnerMarius Swart· solo GP
Co-investorsSpeedinvestAhren Innovation CapitalForesight GroupParkwalk AdvisorsPortfolio Ventures
Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.
AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSaaSMunich, DE
Felix Steinbrenner(CEO)inDanielSamuelPhilip BrinkmannFabian Warmdt
PartnerMarius Swart· solo GP
Co-investorsFoundersX VenturesFrontline VenturesSoma CapitalY CombinatorFAST — by GETTYLABFoundersX+4 more
ChemFinity Technologies develops highly selective sorbent and membrane materials for molecular separations used in resource recovery, including extracting critical minerals, metals, and water from waste streams.
CleantechDeep TechNew MaterialsBrooklyn, US
Adam Uliana(Co-inventor / Co-founder)inEver Velasquez(Co-inventor / Co-founder)in
PartnerMarius Swart· solo GP
Co-investorsAt One VenturesCreative Destruction Lab (CDL)Third DerivativeClimate CapitalWovenEarth
Metri is a biotech company developing first-in-class, disease-modifying therapeutics for endometriosis and other uterine diseases originating in the endometrium.
BiotechFemTechHealthtech
Ashley Abel(Co-Founder & CEO)inBerna Sozen, PhD(Academic Co-Founder & SAB Chair)
PartnerMarius Swart· solo GP
Co-investorsFifty YearsPillar VC
Builds tools to replace silver with copper in solar manufacturing.
PartnerMarius Swart· solo GP
Co-investorsBaruch Future VenturesPrelude VenturesAhren Innovation CapitalVoyager PartnersWovenEarth
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.